This article is part of the supplement: Eleventh International Conference on Bioinformatics (InCoB2012): Bioinformatics

Open Access Proceedings

Sanjeevini: a freely accessible web-server for target directed lead molecule discovery

B Jayaram123*, Tanya Singh12, Goutam Mukherjee12, Abhinav Mathur2, Shashank Shekhar2 and Vandana Shekhar2

Author Affiliations

1 Department of Chemistry, Indian Institute of Technology, Hauz Khas, New Delhi-110016, India

2 Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology, Hauz Khas, New Delhi-110016, India

3 Kusuma School of Biological Sciences, Indian Institute of Technology, Hauz Khas, New Delhi-110016, India

For all author emails, please log on.

BMC Bioinformatics 2012, 13(Suppl 17):S7  doi:10.1186/1471-2105-13-S17-S7

Published: 13 December 2012



Computational methods utilizing the structural and functional information help to understand specific molecular recognition events between the target biomolecule and candidate hits and make it possible to design improved lead molecules for the target.


Sanjeevini represents a massive on-going scientific endeavor to provide to the user, a freely accessible state of the art software suite for protein and DNA targeted lead molecule discovery. It builds in several features, including automated detection of active sites, scanning against a million compound library for identifying hit molecules, all atom based docking and scoring and various other utilities to design molecules with desired affinity and specificity against biomolecular targets. Each of the modules is thoroughly validated on a large dataset of protein/DNA drug targets.


The article presents Sanjeevini, a freely accessible user friendly web-server, to aid in drug discovery. It is implemented on a tera flop cluster and made accessible via a web-interface at webcite. A brief description of various modules, their scientific basis, validation, and how to use the server to develop in silico suggestions of lead molecules is provided.